-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
Automated machine-learning approach for next generation profiling of sequence alterations, mutation burden, microsatellite instability, and structural variants in human cancers
Study
EGAS00001005556
-
Foundation Medicine Genomic Data Used to Identify Prognostic Markers and Fusion Genes in Multiple Myeloma
Study
EGAS00001002874
-
Scottish High Grade Serous Ovarian Cancer
Study
EGAS00001004410
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
APOBEC mutagenesis is a common process in normal human small intestine
Dataset
EGAD00001008764
-
Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancers
Study
EGAS00001002604
-
Identifying transcriptional programs underlying anti-EGFR small molecule response and resistance with TraCe-seq
Study
EGAS00001005405
-
Characterization of Cell Free Plasma Methyl-DNA From Xenografted Tumors to Guide the Selection of Diagnostic Markers for Early-Stage Cancers
Study
EGAS00001006175
-
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
Study
EGAS00001006059
-
HCA_Thymus_Disease_DiGeorge_Transplant_RNA
Study
EGAS00001004025
-
High-resolution testing of ctDNA dynamics predicts survival in metastatic NSCLC
Study
EGAS00001006703
-
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial
Study
EGAS00001006838
-
TK-EPN862 - Patient-dervied xenograft model of Posterior Fossa A Ependymoma - RNAseq
Study
EGAS00001006844
-
Effects of 2DG, Galactose, or Oligomycin on the epigenome remodeling induce by T cells activation.
Study
EGAS00001007115
-
Mapping the epigenomic landscape of human monocytes following innate immune activation reveals context-specific mechanisms driving endotoxin tolerance
Study
EGAS00001007362
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – Whole exome sequencing
Study
EGAS00001004832
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions(H021/INF)
Study
EGAS00001006939
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077
-
The Haemgen RBC study
Study
EGAS00000000132
-
Warm_autopsy__mutational_signatures_and_clonal_units
Study
EGAS00001002216
-
SABE_1171_WGS_GVCF_IDX
Dataset
EGAD00001008203